NREP
NEW REPRESENTATIVE AT IB RECEIVED
06/25/2026
Back to search
Official data from USPTO
GREENLIGHT CLINICAL
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
37
Latest update
06/25/2026
Classification
Registered
Trademark type
Combined
Nice classes
42, 44
Filing date
05/02/2018
Registration date
10/22/2019
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/08/2026
Last transaction
06/25/2026
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
3
Owner type
81
Owner location
AU
Examiner
CIANCI, RYAN MICHAEL
Law office
M70
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of a globe comprised of puzzle pieces. The wording "GREENLIGHT" and "CLINICAL" appear beneath the globe.
Holders and representatives
Holders
GREENLIGHT CLINICAL PTY LTD
Representatives
Christie Baty Hudgins Finnegan, Henderson, Farabow, et al.
Technical classification
Nice Classes
Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Conducting clinical trials for others; Advisory services relating to scientific research; Analytical laboratory services in the field of pharmacodynamics and pharmacokinetics; Conducting of scientific feasibility studies; Conducting surveys; Evaluation of performance against bench-mark referencesquality control for others; Medical laboratory services; Management of scientific research projectsconducting scientific research; Medical research; Pharmaceutical research services; Preparation of reports relating to scientific research; Preparation of scientific reports; Preparation of technical manuals in the form of providing information on the chemical properties of pharmaceuticals; Product testing; Advisory services relating to product testing; Quality control; Quality control testing; Scientific research into the development of new products; Research relating to medicine; Research relating to pharmaceuticals; Safety testing of products; Scientific laboratory services; Scientific research; Scientific research in the field of pharmacy; Services for assessing the efficiency of pharmaceuticals; Services for assessing the safety of pharmaceuticals
Class 44
Pharmaceutical advisory services; Advisory services relating to medical services; Advisory services relating to pharmaceutical products; Advisory services relating to pharmacology; Advisory services relating to medical problems; Advisory services relating to diseases; Compilation of medical reports; Consultancy and advisory services in relation to medical services; Health care consultancy services; Medical advisory services; Medical clinic services; Medical consulting services relating to offshore medical services; Medical equipment rental; Medical services in the form of OncologyOphthalmologyCardiovascularCNSDermatology; Ophthalmological services; Medical services in the form of Ophthalmology; Pharmacy advisory services in the form of providing information about the dispensing of pharmaceuticals; Provision of information relating to medicine; Rental of equipment for medical purposes; Rental of medical apparatus; Rental of medical equipment and instruments
Publications
History of USPTO decisions and trademark events.
37 publications found
C71T
CANCELLED SECTION 71
05/08/2026
NREP
NEW REPRESENTATIVE AT IB RECEIVED
07/25/2025
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
10/22/2024
NREP
NEW REPRESENTATIVE AT IB RECEIVED
05/20/2023
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
03/06/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
02/13/2020
FIMP
FINAL DISPOSITION PROCESSED
02/13/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
01/22/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
10/22/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/06/2019
PUBO
PUBLISHED FOR OPPOSITION
08/06/2019
GPNX
NOTIFICATION PROCESSED BY IB
08/02/2019
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
07/17/2019
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
07/17/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/17/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/01/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
06/18/2019
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
06/18/2019
GNEA
EXAMINERS AMENDMENT E-MAILED
06/18/2019
CNEA
EXAMINERS AMENDMENT -WRITTEN
06/18/2019
ALIE
ASSIGNED TO LIE
06/14/2019
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
11/30/2018
GNSL
LETTER OF SUSPENSION E-MAILED
11/30/2018
CNSL
SUSPENSION LETTER WRITTEN
11/30/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/29/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/28/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/28/2018
RFNT
REFUSAL PROCESSED BY IB
10/13/2018
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
09/22/2018
RFRR
REFUSAL PROCESSED BY MPU
09/22/2018
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
09/19/2018
CNRT
NON-FINAL ACTION WRITTEN
09/18/2018
MAFR
APPLICATION FILING RECEIPT MAILED
09/18/2018
DOCK
ASSIGNED TO EXAMINER
09/12/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/12/2018
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
09/06/2018
Continuous trademark protection
Get notified about every new filing that threatens GREENLIGHT CLINICAL or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.